Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | Pomoč | SLO | ENG

Naslov:Development and validation of an LC-MS/MS bioanalytical method for simultaneous determination of five main metabolites from the folate-methionine cycle in biological samples: Implications for anti-folate treatment
Avtorji:ID Rotman Primec, Jaka (Avtor)
ID Geršak, Ksenija (Avtor)
ID Mlinarič-Raščan, Irena (Avtor)
ID Urbančič, Dunja (Avtor)
ID Roškar, Robert (Avtor)
Datoteke:.pdf PDF - Predstavitvena datoteka, prenos (1,61 MB)
MD5: 299614569FE757F106B5768D06042A59
 
URL URL - Izvorni URL, za dostop obiščite https://www.sciencedirect.com/science/article/pii/S0026265X2503749X
 
Jezik:Angleški jezik
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:Logo UKC LJ - Univerzitetni klinični center Ljubljana
Povzetek:The folate-methionine cycle metabolites are essential for methylation reactions and cell growth, with their imbalances implicated in cardiovascular disease, neural tube defects, cancer, and psychiatric disorders. Reliable quantification of these metabolites is important for disease prevention and monitoring of antifolate therapies. However, existing analytical methods are often limited by a low number of analytes, lengthy sample preparation, high reagent consumption, derivatisation requirements or lack of efficiency for simultaneous analysis. In this study, we report the development and validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of five key metabolites: 5-methyltetrahydrofolate, S-adenosylmethionine, S-adenosylhomocysteine, folic acid, and homocysteine in biological samples utilising simple and fast sample preparation by protein precipitation. Method validation followed the guideline M10 on bioanalytical method validation, demonstrating selectivity, concentration-response relationship, precision, accuracy and stability across short- and long-term storage. The method covered wide dynamic ranges between the lower and upper limits of quantification, namely 50–4000 μg/L for homocysteine, 500–10,000 μg/L for S-adenosylmethionine, 2.5–50 μg/L for S-adenosylhomocysteine, 2.5–100 μg/L for folic acid and 2.5–50 μg/L for 5-methyltetrahydrofolate. In addition, the method's robustness was shown in endogenous matrices of six different cell lines. Applicability was demonstrated on human lymphoblastoid cells treated with methotrexate, a known antifolate, revealing expected metabolic changes; increase in intracellular levels of folic acid and homocysteine, and decreased levels of 5-methyltetrahydrofolate and S-adenosylmethionine. These results highlight the ability of the method to detect metabolic changes and its potential as a robust tool for assessing methylation and folate status in biomedical research.
Ključne besede:LC-MS/MS, folic acid, 5-methyltetrahydrofolate, S-adenosylmethionine, S-adenosylhomocysteine, homocysteine, cell lysates
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Leto izida:2026
Št. strani:1-10 str.
Številčenje:Vol. 220, [art. no.] ǂ116399
PID:20.500.12556/DiRROS-28816 Novo okno
UDK:543.2/.9
ISSN pri članku:1095-9149
DOI:10.1016/j.microc.2025.116399 Novo okno
COBISS.SI-ID:260447235 Novo okno
Opomba:Nasl. z nasl. zaslona; Opis vira z dne 8. 12. 2025;
Datum objave v DiRROS:08.04.2026
Število ogledov:275
Število prenosov:220
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
  
Objavi na:Bookmark and Share


Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Microchemical journal
Založnik:Elsevier
ISSN:1095-9149
COBISS.SI-ID:23088645 Novo okno

Gradivo je financirano iz projekta

Financer:Drugi - Drug financer ali več financerjev
Številka projekta:P1-0208
Naslov:Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:P1-0189-2018
Naslov:Farmacevtska tehnologija: od dostavnih sistemov učinkovin do terapijskih izidov zdravil pri otrocih in starostnikih

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:P3-0124-2020
Naslov:Metabolni in prirojeni dejavniki reproduktivnega zdravja, porod III

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:MR
Naslov:Mladi raziskovalec
Akronim:MR

Financer:Drugi - Drug financer ali več financerjev
Program financ.:Ministrstvo za izobraževanje, znanost in šport
Številka projekta:MR51882
Naslov:Ministry of Education, Science, and Sport (MIZŠ) and the European Regional Development Fund OP20.05187 RI-SI-EATRIS

Financer:EC - European Commission
Številka projekta:101057442
Naslov:BUILDING A SUSTAINABLE EUROPEAN INNOVATION PLATFORM TO ENHANCE THE REPURPOSING OF MEDICINES FOR ALL
Akronim:REMEDi4ALL

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:LC-MS/MS, folna kislina, 5-metiltetrahidrofolat, S-adenozilmetionin, S-adenozilhomocistein, homocistein, celični lizati


Nazaj